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Abstract 
There are no two identical leaves in the world, so how to find effective 
markers or features to distinguish them is an important issue. Function 
transformation, such as f(x,y) and f(x,y,z), can transform two, three, or 
multiple input/observation variables (in biology, it generally refers to the 
observed/measured value of biomarkers, biological characteristics, or 
other indicators) into a new output variable (new characteristics or 
indicators). This provided us a chance to re-cognize objective things or 
relationships beyond the original measurements. For example, Body Mass 
Index, which transform weight and high into a new indicator BMI=x/y2 
(where x is weight and y is high), is commonly used in to gauge obesity. 
Here, we proposed a new system, Funomics (Function Transformation 
Omics), for understanding the world in a different perspective. Funome 
can be understood as a set of math functions consist of basic elementary 
functions (such as power functions and exponential functions) and basic 
mathematical operations (such as addition, subtraction). By scanning the 
whole Funome, researchers can identify some special functions (called 
handsome functions) which can generate the novel important output 
variable (characteristics or indicators). We also start “the Funome 
project” to develop novel methods, function library and analysis software 
for Funome studies. The Funome project will accelerate the discovery of 
new useful indicators or characteristics, will improve the utilization 
efficiency of directly measured data, and will enhance our ability to 
understand the world. The analysis tools and data resources about the 
Funome project can be found gradually at http://www.funome.com.  
Introduction 
An important goal in scientific research is to find some effective 
characteristics to distinguish objective things. Especially in the field of 
life and biomedical science, the researchers hope to find some biomarkers 
to detect disease, such as cancer1,2, diabetes3 and alzheimer's disease4, or 
to test whether a treatment is working5. With the development of 
biotechnology, such as gene chip and sequencing technology6,7, 
biomarkers of various omics (genome, transcriptome, proteome, 
epigenome, etc.)8 have been widely and directly measured. However, the 
scanning of single markers can only provide limited understanding of 
complex disease.  
  Math function transformation is an effective way to transform two, 
three, or multiple observed/measured values of biomarkers (or biological 
characteristics) into a new useful characteristic/indicator. One example is 
Body Mass Index (BMI) which is an important indicator of body fat, and 
widely be used in scientific research9,10. Let x  is person’s weight and y  
is person’s high, 2/),( yxyxfBMI   is actually a function 
transformation which transform the person’s weight and height to a new 
indicator. Another example is  plasma amyloid-β  (Aβ) biomarkers for 
Alzheimer’s disease11. Akinori Nakamura et al. measured plasma 
amyloid-β biomarkers by immunoprecipitation coupled with mass 
spectrometry, and found Aβ1-40/Aβ1-42 ratio has a high performance to 
predict individual brain amyloid-β -positive or -negative status. Let x  is 
Aβ1-40 and y  is Aβ1-42, yxyxfF /),(   is a function transformation 
which transform the Aβ1-40 and Aβ1-42 to a new indicator. The new 
indicator is a potentially clinically useful candidate for plasma biomarker 
as surrogates for brain Aβ burden.  
There are a lot of classic examples, such as waist-hip ratio (WHR)12, 
we will not enumerate out them one by one. In order to extend the 
application of function transformation, we propose a strategy, Funomics 
(Function Transformation Omics), to discover new useful indicators or 
characteristics by scanning a set of functions. 
The Funome Project 
Funome  
A funome is a set of function transformations. In all kinds of function 
transformations, the math functions generated from the basic elementary 
function are the most easily understood by researchers. In the Funome 
Project, we mainly consider the common mathematical functions, such as 
Two-Variable Functions (2v Funome), Three-Variable Functions (3v 
Funome), or some special function sets (special Funomes). 
The generation of functions 
All the functions in current version of ‘the Funome Project’ were 
generated from the basic elementary function, such as exponential 
function, power function, exponential function, logarithmic function, 
trigonometric function, anti-trigonometric function. Basic mathematical 
operations, such as addition, subtraction, multiplication, division, powers 
and compound, were used to procedure the math functions.  
Identifying the novel indicators/characteristics by scanning the funome 
An important task of ‘the Funome Project’ is to identify novel 
indicators/characteristics from the original observed/measured variables 
(biomarkers or biological characteristics). For some omics data, such as 
genome, transcriptome and proteome, we will scan the funome to find 
new indicators which can distinguish disease phenotypes or drug targets. 
The new indicators may constituted by several biomarkers/characteristics 
that are not significant.  
Handsome function 
In the Funome Project, the function ( ,...),,( zyxfF  ) identified by 
scanning funome is called handsome function. The dependent variable, F , 
in handsome function can also be called handsome 
indicator/characteristic. The independent variable, ,...,, zyx , of handsome 
function can be called handsome original variables. For example, 
2/),( yxyxfFBMI  ,  where 2/ yxF   is a handsome function, F is a 
handsome indicator named BMI, yx,  (weight and height) are handsome 
original variables. 
Develop the Funome tools  
Another task of ‘the Funome Project’ is to develop some tools to scan the 
funome and identify handsome functions. We will gradually publish the 
function library and software on our website http://www.funome.com. 
Discussion 
To find effective markers, features or indicators that can distinguish 
objective things, here, we developed a funome project. When we use 
funome to solve practical problems, there are still some points to pay 
attention to. (1) There are too many math functions in the function library, 
and researchers need to choose some common, important functions in 
their study. We will gradually provide some important function sets for 
downloading and using. (2) For whole genome, transcriptome and 
proteome data, there were too many markers detected through chips and 
sequencing. Under the current speed limit of computer, it is impossible to 
scan all functions for all the markers. We recommend that researchers can 
select several interesting functions to scan the whole genome or 
transcriptome. 
In the funome study, some pattern recognition methods, such as 
classification and discrimination, can also be used to improve the 
efficiency of identifying novel indicator/characteristic.  
Although funome comes from the life science, it can be applied to 
other fields, such as Physics and Economics.  
We also hope some excellent indicators/characteristics identified by the 
funome strategy can be applied in the field of artificial intelligence. 
Acknowledgements 
This work was supported in part by the National Natural Science 
Foundation of China (Grant No. 91746113). 
References 
1  Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate 
cancer. Nature 419, 624‐629, doi:10.1038/nature01075 (2002). 
2  Kuehn,  B.  M.  Promising  marker  found  for  deadly  prostate  cancer.  JAMA  301,  1008, 
doi:10.1001/jama.2009.299 (2009). 
3  Wareham, N. J. & Pfister, R. Diabetes: glycated hemoglobin  is a marker of diabetes and CVD 
risk. Nat Rev Cardiol 7, 367‐368, doi:10.1038/nrcardio.2010.84 (2010). 
4  Vos,  S.  J.  &  Fagan,  A.  M.  Alzheimer's  disease  biomarker  states.  Lancet  Neurol  15,  25‐26, 
doi:10.1016/s1474‐4422(15)00335‐x (2016). 
5  Xing, M., Haugen,  B.  R. &  Schlumberger, M.  Progress  in molecular‐based management  of 
differentiated  thyroid  cancer.  Lancet  381,  1058‐1069,  doi:10.1016/s0140‐6736(13)60109‐9 
(2013). 
6  Shendure,  J.  et  al. DNA  sequencing  at 40: past, present  and  future. Nature  550, 345‐353, 
doi:10.1038/nature24286 (2017). 
7  Green, E. D., Rubin, E. M. & Olson, M. V. The future of DNA sequencing. Nature 550, 179‐181, 
doi:10.1038/550179a (2017). 
8  McShane, L. M. et al. Criteria  for the use of omics‐based predictors  in clinical trials. Nature 
502, 317‐320, doi:10.1038/nature12564 (2013). 
9  Locke, A. E. et al. Genetic studies of body mass  index yield new  insights for obesity biology. 
Nature 518, 197‐206, doi:10.1038/nature14177 (2015). 
10  Wahl,  S.  et  al.  Epigenome‐wide  association  study  of  body  mass  index,  and  the  adverse 
outcomes of adiposity. Nature 541, 81‐86, doi:10.1038/nature20784 (2017). 
11  Nakamura,  A.  et  al.  High  performance  plasma  amyloid‐beta  biomarkers  for  Alzheimer's 
disease. Nature 554, 249‐254, doi:10.1038/nature25456 (2018). 
12  Biggs, M. L. et al. Association between adiposity in midlife and older age and risk of diabetes 
in older adults. JAMA 303, 2504‐2512, doi:10.1001/jama.2010.843 (2010). 
